P
Precipio Inc (PRPO)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
$19.96
-2.17 (-9.81%)
Market Cap: $39.68M
Last updated: Nov 17, 2026 at 11:06 AM ET
Precipio Inc (PRPO) Valuation Multiples
Precipio (PRPO) trades at 1.3x sales and 2.4x book value. Its P/S of 1.3x is in line with its 5-year median. Its forward P/E is 15.4x.
Current Multiples
Its enterprise value is 40.5x its EBITDA. Its free cash flow yield is 3.9%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 15.4x |
| Price to sales | 1.3x |
| Price to book | 2.4x |
| EV/EBITDA | 40.5x |
| Price to FCF | 25.8x |
| EV/FCF | 23.4x |
| PEG | N/A |
| FCF yield | 3.9% |
Historical Medians
Against its 10-year medians, its P/B is 84.6% above 1.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.3x | 1.3x | N/A |
| P/B | 2.4x | 1.1x | 1.3x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 0.4x in 2024 to 5.2x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $22.98 | N/A | 1.5x | 2.5x |
| 2024 | $5.54 | N/A | 0.4x | 0.7x |
| 2023 | $6.50 | N/A | 0.6x | 0.6x |
| 2022 | $11.03 | N/A | 1.3x | 0.8x |
| 2021 | $31.60 | N/A | 3.8x | 1.5x |
| 2020 | $41.40 | N/A | 3.3x | 2.6x |
| 2019 | $41.00 | N/A | 5.2x | 1.2x |
| 2018 | $46.18 | N/A | N/A | 26.0x |
| 2017 | $359.82 | N/A | N/A | 131.0x |
| 2016 | $85.22 | 0.7x | N/A | N/A |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PRPO
What is PRPO's forward P/E ratio?
Precipio has a forward P/E ratio of 15.4x.
Is PRPO stock overvalued?
GNG's valuation label for PRPO is Overvalued.
What is PRPO's price to sales ratio?
Precipio has a price to sales ratio of 1.3x.
PRPO pages: Overview, Earnings, Financials, Valuation, Competitors